Rock Springs Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Rock Springs Capital Management’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-437,329	Closed	-$1.18M	–	120
2023 Q3	$1.18M	Hold	437,329	–	–	0.03%	107
2023 Q2	$4.08M	Hold	437,329	–	–	0.1%	91
2023 Q1	$3.88M	Hold	437,329	–	–	0.09%	95
2022 Q4	$2.18M	Hold	437,329	–	–	0.05%	103
2022 Q3	$2.54M	Hold	437,329	–	–	0.07%	107
2022 Q2	$2.42M	Hold	437,329	–	–	0.07%	110
2022 Q1	$5.04M	Hold	437,329	–	–	0.13%	104
2021 Q4	$5.54M	Buy	+437,329	New	+$6.6M	0.13%	116

Other funds holding THRX

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return